As of 2026-09-12, the Intrinsic Value of Replimune Group Inc (REPL) is -18.68 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 13.24 USD, the upside of Replimune Group Inc is -241.09%.
Based on its market price of 13.24 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 241.09%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -18.68 - -18.68 | -18.68 | -241.09% |
| P/E | (88.54) - (110.59) | (100.22) | -856.9% |
| DDM - Stable | (32.41) - (153.60) | (93.00) | -802.4% |
| DDM - Multi | (28.18) - (109.36) | (45.47) | -443.4% |
| Market Cap (mil) | 1,112.56 |
| Beta | 0.46 |
| Outstanding shares (mil) | 84.03 |
| Enterprise Value (mil) | 1,011.63 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.13% |
| Cost of Debt | 5.00% |
| WACC | 8.81% |